Re: The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? J. Feliciano, E. Teper, M. Ferrandino, R. J. Macchia, W. Blank, I. Grunberger and I. Colon J Urol 2008; 179: 952-955.
Ng
Chi-Fai
CF
Chan
Shu-yin
SY
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D001424:Bacterial Infections / Q000453:epidemiology / Q000517:prevention & control*; D001707:Biopsy, Needle / Q000009:adverse effects* / Q000379:methods; D015331:Cohort Studies; D024881:Drug Resistance, Bacterial; D019160:Endosonography / Q000379:methods; D024841:Fluoroquinolones / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000601:surgery; D012189:Retrospective Studies; D018570:Risk Assessment; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones